Long-Term Management of Generalised Anxiety Disorder with Low-Dose Continuous Infusions of Flumazenil: A Case Series.
Alexander T GalloStephen AddisVlad MartynHishani RamanathanGrace K WilkersonSean D HoodHans StampferGary K HulsePublished in: Behavioral sciences (Basel, Switzerland) (2022)
Data suggest that low-dose continuous flumazenil infusion manages GAD symptoms and is safe. Although these results are promising, future randomised control trials are required to confirm these results.